Aethlon Medical
AEMD
23 hedge funds and large institutions have $388K invested in Aethlon Medical in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
9% more capital invested
Capital invested by funds: $355K → $388K (+$32.7K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
15% less funds holding
Funds holding: 27 → 23 (-4)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$41K |
| 2 |
Two Sigma Advisers
New York
|
+$16.2K |
| 3 |
N
Natixis
Paris,
France
|
+$10.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$9.79K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.65K |
Top Sellers
| 1 |
Jane Street
New York
|
-$38.6K |
| 2 |
Renaissance Technologies
New York
|
-$28K |
| 3 |
VF
Virtu Financial
New York
|
-$17K |
| 4 |
E
Ergoteles
New York
|
-$13.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PGAM
26
Princeton Global Asset Management
Princeton,
New Jersey
| $6 | – | – | – |
|
|
27
Jane Street
New York
| – | -$38.6K | -175 | Closed |
|
|
28
Renaissance Technologies
New York
| – | -$28K | -126 | Closed |
|
|
VF
29
Virtu Financial
New York
| – | -$17K | -77 | Closed |
|
|
E
30
Ergoteles
New York
| – | -$13.9K | -63 | Closed |
|
|
31
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$13.3K | -61 | Closed |
|
32
Goldman Sachs
New York
| – | -$3.92K | -18 | Closed |
|
AEMD Hedge Fund Activity: Q1 2023 in Review
23 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2023, worth a combined $388K — up 9.2% from $355K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of AEMD and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Two Sigma Investments, adding an estimated $41K. The largest seller was Jane Street, exiting entirely with an estimated $38.6K sold.
- 23 institutional investors held Aethlon Medical (AEMD) as of Q1 2023, down from 27 in Q4 2022.
- Funds reported $388K of Aethlon Medical stock for Q1 2023, up 9.2% quarter-over-quarter.
- 3 funds opened new Aethlon Medical positions in Q1 2023 and 6 closed out, a net change of -3 holders.
- The largest Aethlon Medical buyer in Q1 2023 was Two Sigma Investments, an estimated $41K added.
- The largest Aethlon Medical seller in Q1 2023 was Jane Street, an estimated $38.6K sold.
Based on aggregated 13F filings for Q1 2023.